Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(?)-carboxymethyl lysine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples